Breaking News Instant updates and real-time market news.

BCRX

BioCryst

$8.48

0.04 (0.47%)

10:25
04/16/19
04/16
10:25
04/16/19
10:25

BioCryst participates in a conference call with JPMorgan

SMid Biotech Analyst Fye holds a conference call with CEO Stonehouse and CMO Sheridan on April 16 at 11 am hosted by JPMorgan.

  • 16

    Apr

  • 18

    Apr

BCRX BioCryst
$8.48

0.04 (0.47%)

03/04/19
PIPR
03/04/19
NO CHANGE
Target $15
PIPR
Overweight
Piper Jaffray expects positive results from BioCryst's Phase III APeX-2 trial
Piper Jaffray analyst Tyler Van Buren "fully" expects positive results from BioCryst's Phase III APeX-2 trial next quarter and notes that the increased enrollment and improved powering is an encouraging development. Additionally, the analyst says that recent full presentation of the Phase II ZENITH-1 results for the 7353 oral liquid program continue to give him a high level of confidence in the future outcome of the Phase III trial. In addition to these two late stage programs, the company's pipeline is expanding rapidly with IV antiviral galidesivir, BCX9250 for FOP, and BCX9930 for complement-mediated diseases all entering the clinic this year, he adds. Van Buren reiterates an Overweight rating and $15 price target on the shares as he continues to have a high level of confidence in the $500M-plus potential of each the 7353 oral capsule and oral liquid assets and believes that the early-stage pipeline could generate significant additional value.
03/06/19
PIPR
03/06/19
NO CHANGE
PIPR
Departure of Gottlieb brings some biopharma uncertainty, says Piper Jaffray
Piper Jaffray remains "largely bullish" on the biopharma sector but acknowledges a "new and unexpected" source of uncertainty now with the announced departure of FDA commissioner Scott Gottlieb, analysts led by Christopher Raymond tell investors in a research note. With a track record of favoring innovation and pushing for increased regulatory efficiency while also advocating for more competition, Dr. Gottlieb was about as "market friendly, patient focused and industry friendly as one could have hoped," Piper writes. The firm adds that while it has no reason to believe the next commissioner "will be quite as radical and potentially damaging to the industry," it does think investors would do well to watch the selection process very closely.
03/12/19
PIPR
03/12/19
NO CHANGE
PIPR
Biopharma stocks should be up sharply on Sharpless selection, says Piper Jaffray
Piper Jaffray analyst Christopher Raymond said he expects biopharma stocks to be up sharply on news that former National Cancer Institute director Ned Sharpless will be named acting FDA commissioner. The biotech sector "experienced a swoon of sorts" since Scott Gottlieb announced his departure, but with the announcement of Gottlieb's favored choice as successor Raymond believes the FDA will remain "on its current industry-friendly and efficiency driven trajectory," the analyst tells investors.
04/02/19
LEHM
04/02/19
NO CHANGE
Target $8
LEHM
Equal Weight
BioCryst price target raised to $8 from $6 at Barclays
Barclays analyst Gena Wang raised her price target for BioCryst Pharmaceuticals to $8 from $6 following a deep dive ahead of the BCX7353 APeX-2 Phase 3 readout in Q2 for the prevention of hereditary angioedema attacks. The analyst believes APeX-2 is "well powered to allow for statistical significance" with only greater than 25-30% attack reduction. However, she continues to see some risk in the trial outcome and a high bar for future commercial uptake. Wang keeps an Equal Weight rating on BioCryst.

TODAY'S FREE FLY STORIES

XLNX

Xilinx

$139.79

2.66 (1.94%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Downgrade
Xilinx rating change  »

Xilinx downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CIGI

Colliers International

$69.14

-0.39 (-0.56%)

07:44
04/25/19
04/25
07:44
04/25/19
07:44
Hot Stocks
Colliers International acquires affiliate in Sweden »

Colliers International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:43
04/25/19
04/25
07:43
04/25/19
07:43
Earnings
AbbVie raises FY19 adj. EPS view to $8.73-$8.83 from $8.65-$8.75 »

FY19 consensus $8.69. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HAS

Hasbro

$103.18

2.84 (2.83%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Downgrade
Hasbro rating change  »

Hasbro downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 29

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

, GE

General Electric

$9.32

-0.025 (-0.27%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Wabtec CEO Ray Betler to retire, Rafael Santana to succeed »

Wabtec (WAB) announced…

WAB

Wabtec

$76.57

-0.19 (-0.25%)

GE

General Electric

$9.32

-0.025 (-0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 08

    May

  • 08

    May

  • 21

    May

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Hot Stocks
Breaking Hot Stocks news story on AbbVie »

AbbVie raises FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

ABBV

AbbVie

$78.71

0.06 (0.08%)

07:42
04/25/19
04/25
07:42
04/25/19
07:42
Earnings
AbbVie reports Q1 adjusted EPS $2.14, consensus $2.06 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 28

    Apr

  • 03

    May

  • 03

    May

  • 04

    May

  • 18

    May

  • 31

    May

  • 05

    Jun

HBAN

Huntington Bancshares

$13.75

-0.04 (-0.29%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Earnings
Huntington Bancshares sees FY19 revenue up 4%-7%, consensus $4.76B »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    May

  • 31

    May

  • 29

    Aug

REPL

Replimune Group

$15.32

1 (6.98%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Initiation
Replimune Group initiated  »

Replimune Group added to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALKS

Alkermes

$34.80

0.6 (1.75%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Hot Stocks
Alkermes reports Q1 Vivitrol revenue $69.2M vs. $62.7M last year »

Reports Q1 Aristada…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

FCN

FTI Consulting

$78.95

-0.04 (-0.05%)

07:40
04/25/19
04/25
07:40
04/25/19
07:40
Earnings
FTI Consulting backs FY19 adj. EPS view $3.50-$4.00, consensus $3.71 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

RRC

Range Resources

$9.76

0.08 (0.83%)

07:39
04/25/19
04/25
07:39
04/25/19
07:39
Downgrade
Range Resources rating change  »

Range Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

  • 22

    May

SWK

Stanley Black & Decker

$145.79

-1.58 (-1.07%)

07:38
04/25/19
04/25
07:38
04/25/19
07:38
Recommendations
Stanley Black & Decker analyst commentary  »

Stanley Black &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 16

    May

FCN

FTI Consulting

$78.95

-0.04 (-0.05%)

07:37
04/25/19
04/25
07:37
04/25/19
07:37
Earnings
FTI Consulting reports Q1 adj. EPS $1.63, consensus 99c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

NCI

Navigant Consulting

$21.00

0.38 (1.84%)

07:37
04/25/19
04/25
07:37
04/25/19
07:37
Earnings
Navigant Consulting backs FY19 adjusted EPS view 85c-$1.00, consensus 89c »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 23

    May

  • 28

    May

SAH

Sonic Automotive

$15.84

0.45 (2.92%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Earnings
Sonic Automotive reports Q1 adjusted EPS 39c, consensus 23c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 13

    Nov

TSLA

Tesla

$258.70

-5.15 (-1.95%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Recommendations
Tesla analyst commentary  »

Tesla seems less opposed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWB

Bridgewater Bancshares

$10.53

-0.07 (-0.66%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Earnings
Bridgewater Bancshares reports Q1 EPS 23c, consensus 24c »

Reports Q1 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$182.64

-1.13 (-0.61%)

07:36
04/25/19
04/25
07:36
04/25/19
07:36
Recommendations
Facebook analyst commentary at Morgan Stanley »

Facebook price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 30

    May

  • 03

    Jun

NCI

Navigant Consulting

$21.00

0.38 (1.84%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Hot Stocks
Navigant Consulting CEO says 'poised to deliver' 2019 cont ops. guidance targets »

CEO Julie Howard said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 23

    May

  • 28

    May

NOW

ServiceNow

$242.41

-1.085 (-0.45%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Recommendations
ServiceNow analyst commentary  »

ServiceNow price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

WAB

Wabtec

$76.57

-0.19 (-0.25%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Earnings
Wabtec backs FY19 adj. EPS view $4.00-$4.20, consensus $4.15 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 08

    May

  • 21

    May

  • 05

    Jun

  • 13

    Nov

FB

Facebook

$182.64

-1.13 (-0.61%)

, CVE

Cenovus Energy

$10.19

-0.25 (-2.39%)

07:35
04/25/19
04/25
07:35
04/25/19
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

FB

Facebook

$182.64

-1.13 (-0.61%)

CVE

Cenovus Energy

$10.19

-0.25 (-2.39%)

AMRN

Amarin

$18.47

0.08 (0.44%)

ORCL

Oracle

$55.17

0.23 (0.42%)

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

COP

ConocoPhillips

$64.71

-1.74 (-2.62%)

JNPR

Juniper

$28.73

0.355 (1.25%)

IVZ

Invesco

$21.53

-0.09 (-0.42%)

CSIQ

Canadian Solar

$20.17

-0.085 (-0.42%)

CNSL

Consolidated Communications

$8.89

-0.03 (-0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 25

    Apr

  • 25

    Apr

  • 28

    Apr

  • 29

    Apr

  • 30

    Apr

  • 01

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 10

    May

  • 14

    May

  • 14

    May

  • 22

    May

  • 29

    May

  • 30

    May

  • 03

    Jun

NCI

Navigant Consulting

$21.00

0.38 (1.84%)

07:34
04/25/19
04/25
07:34
04/25/19
07:34
Earnings
Navigant Consulting reports Q1 adjusted EPS 18c, consensus 8c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 14

    May

  • 23

    May

  • 28

    May

ADS

Alliance Data

$163.54

0.47 (0.29%)

07:34
04/25/19
04/25
07:34
04/25/19
07:34
Earnings
Alliance Data lowers FY19 core EPS view to $18.47 from $22.00, consensus $21.82 »

Lowers FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    Jun

  • 13

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.